{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:57:07Z","timestamp":1791309427495,"version":"4.3.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156044","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T17:45:49Z","timestamp":1464198349000},"page":"e0156044","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors"],"prefix":"10.1371","volume":"11","author":[{"given":"Susi","family":"Barollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Bertazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Watutantrige-Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Censi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cavedon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Galuppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Pennelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrogio","family":"Fassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilisa","family":"Citton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Pezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Benna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Opocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Iacobone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","article-title":"EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"39","author":"D Taieb","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref2","first-page":"1161","article-title":"Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET","volume":"45","author":"A Becherer","year":"2004","journal-title":"J Nucl Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","article-title":"Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors","volume":"220","author":"S Hoegerle","year":"2001","journal-title":"Radiology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/17.5.303","article-title":"The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept","volume":"17","author":"AG Pearse","year":"1969","journal-title":"J Histochem Cytochem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2967\/jnumed.107.045708","article-title":"6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications","volume":"49","author":"PL Jager","year":"2008","journal-title":"J Nucl Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0883-2897(92)90002-G","article-title":"Production of 6-[18F]fluoro-L-dopa and its metabolism in vivo\u2014a critical review","volume":"19","author":"A Luxen","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejps.2008.06.015","article-title":"Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2","volume":"35","author":"EM del Amo","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"ref8","first-page":"4819","article-title":"Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer","volume":"30","author":"H Imai","year":"2010","journal-title":"Anticancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.bjc.6604235","article-title":"Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer","volume":"98","author":"K Kaira","year":"2008","journal-title":"Br J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1349-7006.2008.00969.x","article-title":"l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms","volume":"99","author":"K Kaira","year":"2008","journal-title":"Cancer Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond","volume":"121","author":"V Ganapathy","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"JW Lenders","year":"2005","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2265.2007.03008.x","article-title":"Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake","volume":"68","author":"C Mian","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/ERC-11-0337","article-title":"Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models","volume":"19","author":"B Mariniello","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cas.12672","article-title":"Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors","volume":"106","author":"W Wu","year":"2015","journal-title":"Cancer Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.apradiso.2011.02.018","article-title":"BPA uptake does not correlate with LAT1 and Ki67 expressions in tumor samples (results of EORTC trial 11001)","volume":"69","author":"A Wittig","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2009-1054","article-title":"6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess","volume":"94","author":"HB Fiebrich","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1210\/jc.2008-2099","article-title":"Image in endocrinology. Localization of an adrenocorticotropin-producing pheochromocytoma using 18F-dihydroxyphenylalanine positron emission tomography","volume":"94","author":"HB Fiebrich","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","first-page":"122","article-title":"Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review","volume":"57","author":"V Rufini","year":"2013","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2009-2352","article-title":"6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression","volume":"95","author":"C Fottner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cen.12126","article-title":"Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions","volume":"79","author":"S Gabriel","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00259-011-2031-6","article-title":"Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET\/CT in patients with recurrent medullary thyroid carcinoma","volume":"39","author":"G Treglia","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00428-007-0457-9","article-title":"Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract","volume":"451","author":"K Nakanishi","year":"2007","journal-title":"Virchows Arch"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0005-2736(03)00028-2","article-title":"Functional and molecular characteristics of system L in human breast cancer cells","volume":"1611","author":"DB Shennan","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neures.2004.08.003","article-title":"System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells","volume":"50","author":"DK Kim","year":"2004","journal-title":"Neurosci Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jso.20257","article-title":"Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma","volume":"90","author":"H Kobayashi","year":"2005","journal-title":"J Surg Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2967\/jnumed.110.086645","article-title":"O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma","volume":"52","author":"M Hutterer","year":"2011","journal-title":"J Nucl Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/bjc.2012.310","article-title":"Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer","volume":"107","author":"K Kaira","year":"2012","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1349-7006.2011.02151.x","article-title":"Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis","volume":"103","author":"M Furuya","year":"2012","journal-title":"Cancer Sci"},{"key":"ref30","article-title":"Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma","author":"M Namikawa","year":"2014","journal-title":"Hepatol Res"},{"key":"ref31","first-page":"164","article-title":"Expression of glucose transporters in cancers","volume":"1835","author":"L Szablewski","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2967\/jnumed.109.065664","article-title":"18F-FDOPA: a multiple-target molecule","volume":"50","author":"H Minn","year":"2009","journal-title":"J Nucl Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:18:41Z","timestamp":1540225121000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156044"}},"subtitle":[],"editor":[{"given":"Dimitrios","family":"Fotiadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156044","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]}}}